Headline News

 

Roche unveils AXELIOS 1, which is a next-generation sequencing platform set to transform genomic research

Posted on June 29, 2026

GSK announces launch of tender offer to acquire Nuvalent

Posted on June 29, 2026

Efzimfotase alfa highlights meaningful bone health improvements in treatment-naïve paediatric patients with hypophosphatasia, achieving a median difference of 1.67 versus placebo in RGI-C score at week 25 in the MULBERRY Phase III trial

Posted on June 29, 2026

Enhertu gains EU approval as the first tumour-agnostic HER2-directed therapy and antibody drug conjugate for patients with previously treated HER2-positive metastatic solid tumours

Posted on June 29, 2026

Sanofi’s Cenrifki receives approval as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses

Posted on June 29, 2026

Sanofi’s Wayrilz gains approval in Japan for the treatment of immune thrombocytopenia

Posted on June 29, 2026

Lilly outlines how eligible Medicare Part D patients can access its GLP-1 weight management medicines

Posted on June 29, 2026

Lilly launches “The Memory Radio Station” across Europe, inviting the public to visually reconstruct fading memories through generative AI

Posted on June 29, 2026

Lilly’s Jaypirca receives positive CHMP opinion for EU approval in adults with chronic lymphocytic leukaemia across all lines of therapy

Posted on June 29, 2026

Pfizer’s IBRANCE wins FDA approval as a maintenance option in HR+, HER2+ metastatic breast cancer

Posted on June 29, 2026

US FDA approves an additional indication for CAPVAXIVE in children and adolescents aged 2 through 17 at increased risk for pneumococcal disease

Posted on June 22, 2026

Merck’s tulisokibart met primary and key secondary endpoints in the Phase 3 ATLAS-UC induction-only study in patients with moderately to severely active ulcerative colitis

Posted on June 22, 2026

US FDA accepts Gilead’s application for investigational once-weekly oral Yeztugo, potentially the first long-acting pill for HIV prevention

Posted on June 22, 2026

Moderna announces unanimous FDA advisory committee vote in favour of the benefit-risk profile of mRNA-1010, an investigational seasonal influenza vaccine

Posted on June 22, 2026

Cemdisiran regulatory submissions accepted for review by FDA and EMA for the treatment of generalized myasthenia gravis

Posted on June 22, 2026